NR 565 Advanced Pharmacology Fundamentals Week 1–4 & Midterm
Exam Study Guide | Latest Update 2026/2027 | Questions and
Verified Answers with Rationales | 100% Correct | Chamberlain
WEEK 1: Foundations in Pharmacology
Question 1
A nurse practitioner is explaining the drug development process to a patient. Which phase of drug
development focuses on determining safety, dosing, and adverse effects in a small group of healthy
volunteers?
A) Preclinical stage
B) Phase 1 clinical trials
C) Phase 2 clinical trials
D) Phase 3 clinical trials
Answer: B) Phase 1 clinical trials
Explanation: Phase 1 trials involve a small number (20–100) of healthy volunteers to evaluate drug
safety, determine a safe dosage range, identify side effects, and study pharmacokinetics. Preclinical
trials involve animal testing. Phase 2 trials test efficacy in a small patient population. Phase 3 trials
involve larger patient groups to confirm effectiveness, monitor side effects, and compare to standard
treatments.
Question 2
A patient with hypoalbuminemia is prescribed a highly protein-bound medication. The NP should
anticipate which effect?
A) Decreased free drug concentration
B) Increased free drug concentration with potential toxicity
C) No change in drug activity
D) Decreased drug clearance
,Answer: B) Increased free drug concentration with potential toxicity
Explanation: A low albumin level (hypoalbuminemia) reduces protein binding sites. For drugs that are
normally highly protein-bound, this results in a higher fraction of free (active) drug in the circulation.
This can lead to increased drug effect and toxicity at standard doses.
Question 3
The NP prescribes a medication that undergoes significant first-pass metabolism. To avoid this effect,
which route should the NP choose?
A) Oral
B) Sublingual or IV
C) Rectal
D) Intramuscular
Answer: B) Sublingual or IV
Explanation: Sublingual and IV routes bypass the hepatic portal system, allowing the drug to reach
systemic circulation before passing through the liver. Drugs with extensive first-pass metabolism (e.g.,
nitroglycerin, some opioids) are often given via these routes to ensure therapeutic levels.
Question 4
A patient with chronic kidney disease stage 4 requires a medication primarily eliminated by the kidneys.
What is the most appropriate dosing adjustment?
A) Increase the dose
B) Decrease the dose or increase the dosing interval
C) No change needed
D) Administer the medication intravenously
,Answer: B) Decrease the dose or increase the dosing interval
Explanation: In CKD, impaired renal elimination leads to drug accumulation and toxicity risk. Dose
reduction or extended dosing intervals maintain therapeutic levels without toxicity.
Question 5
Pharmacodynamics is best defined as:
A) What the body does to the drug
B) What the drug does to the body
C) The study of drug absorption
D) The study of drug excretion
Answer: B) What the drug does to the body
Explanation: Pharmacodynamics (PD) describes the biochemical and physiologic effects of drugs on the
body, including receptor binding, post-receptor effects, and clinical response. Pharmacokinetics (PK)
describes what the body does to the drug (absorption, distribution, metabolism, excretion).
Question 6
A drug with a narrow therapeutic index requires close monitoring because:
A) It is effective at very low doses
B) The difference between therapeutic and toxic doses is small
C) It has a long half-life
D) It is metabolized by multiple pathways
Answer: B) The difference between therapeutic and toxic doses is small
Explanation: Drugs with a narrow therapeutic index (e.g., warfarin, digoxin, lithium, phenytoin) have a
small margin of safety between effective and toxic doses, requiring therapeutic drug monitoring.
, Question 7
A patient taking warfarin begins eating large amounts of leafy green vegetables. The NP should
anticipate:
A) Increased warfarin effect
B) Decreased warfarin effect
C) No change
D) Increased risk of bleeding
Answer: B) Decreased warfarin effect
Explanation: Leafy green vegetables are high in vitamin K, which counteracts the anticoagulant effect of
warfarin. Patients should maintain consistent vitamin K intake and avoid sudden dietary changes.
Question 8
Which CYP450 enzyme family is responsible for the metabolism of approximately 50-60% of clinically
used drugs?
A) CYP1A2
B) CYP2C9
C) CYP2D6
D) CYP3A4
Answer: D) CYP3A4
Explanation: CYP3A4 is the most abundant CYP450 enzyme in the liver and small intestine, metabolizing
roughly half of all medications. It is involved in the metabolism of statins, calcium channel blockers,
immunosuppressants, and many other drug classes.
Exam Study Guide | Latest Update 2026/2027 | Questions and
Verified Answers with Rationales | 100% Correct | Chamberlain
WEEK 1: Foundations in Pharmacology
Question 1
A nurse practitioner is explaining the drug development process to a patient. Which phase of drug
development focuses on determining safety, dosing, and adverse effects in a small group of healthy
volunteers?
A) Preclinical stage
B) Phase 1 clinical trials
C) Phase 2 clinical trials
D) Phase 3 clinical trials
Answer: B) Phase 1 clinical trials
Explanation: Phase 1 trials involve a small number (20–100) of healthy volunteers to evaluate drug
safety, determine a safe dosage range, identify side effects, and study pharmacokinetics. Preclinical
trials involve animal testing. Phase 2 trials test efficacy in a small patient population. Phase 3 trials
involve larger patient groups to confirm effectiveness, monitor side effects, and compare to standard
treatments.
Question 2
A patient with hypoalbuminemia is prescribed a highly protein-bound medication. The NP should
anticipate which effect?
A) Decreased free drug concentration
B) Increased free drug concentration with potential toxicity
C) No change in drug activity
D) Decreased drug clearance
,Answer: B) Increased free drug concentration with potential toxicity
Explanation: A low albumin level (hypoalbuminemia) reduces protein binding sites. For drugs that are
normally highly protein-bound, this results in a higher fraction of free (active) drug in the circulation.
This can lead to increased drug effect and toxicity at standard doses.
Question 3
The NP prescribes a medication that undergoes significant first-pass metabolism. To avoid this effect,
which route should the NP choose?
A) Oral
B) Sublingual or IV
C) Rectal
D) Intramuscular
Answer: B) Sublingual or IV
Explanation: Sublingual and IV routes bypass the hepatic portal system, allowing the drug to reach
systemic circulation before passing through the liver. Drugs with extensive first-pass metabolism (e.g.,
nitroglycerin, some opioids) are often given via these routes to ensure therapeutic levels.
Question 4
A patient with chronic kidney disease stage 4 requires a medication primarily eliminated by the kidneys.
What is the most appropriate dosing adjustment?
A) Increase the dose
B) Decrease the dose or increase the dosing interval
C) No change needed
D) Administer the medication intravenously
,Answer: B) Decrease the dose or increase the dosing interval
Explanation: In CKD, impaired renal elimination leads to drug accumulation and toxicity risk. Dose
reduction or extended dosing intervals maintain therapeutic levels without toxicity.
Question 5
Pharmacodynamics is best defined as:
A) What the body does to the drug
B) What the drug does to the body
C) The study of drug absorption
D) The study of drug excretion
Answer: B) What the drug does to the body
Explanation: Pharmacodynamics (PD) describes the biochemical and physiologic effects of drugs on the
body, including receptor binding, post-receptor effects, and clinical response. Pharmacokinetics (PK)
describes what the body does to the drug (absorption, distribution, metabolism, excretion).
Question 6
A drug with a narrow therapeutic index requires close monitoring because:
A) It is effective at very low doses
B) The difference between therapeutic and toxic doses is small
C) It has a long half-life
D) It is metabolized by multiple pathways
Answer: B) The difference between therapeutic and toxic doses is small
Explanation: Drugs with a narrow therapeutic index (e.g., warfarin, digoxin, lithium, phenytoin) have a
small margin of safety between effective and toxic doses, requiring therapeutic drug monitoring.
, Question 7
A patient taking warfarin begins eating large amounts of leafy green vegetables. The NP should
anticipate:
A) Increased warfarin effect
B) Decreased warfarin effect
C) No change
D) Increased risk of bleeding
Answer: B) Decreased warfarin effect
Explanation: Leafy green vegetables are high in vitamin K, which counteracts the anticoagulant effect of
warfarin. Patients should maintain consistent vitamin K intake and avoid sudden dietary changes.
Question 8
Which CYP450 enzyme family is responsible for the metabolism of approximately 50-60% of clinically
used drugs?
A) CYP1A2
B) CYP2C9
C) CYP2D6
D) CYP3A4
Answer: D) CYP3A4
Explanation: CYP3A4 is the most abundant CYP450 enzyme in the liver and small intestine, metabolizing
roughly half of all medications. It is involved in the metabolism of statins, calcium channel blockers,
immunosuppressants, and many other drug classes.
